Mott to host live Q & A on COVID vaccines for kids under 12

Mott experts to answer questions about Pfizer’s COVID vaccine for kids ages 5-11, which FDA advisors approved and could be authorized soon

Author | Beata Mostafavi

University of Michigan Health C.S. Mott Children’s Hospital experts will answer questions about the Pfizer vaccine for children ages 5-11 during a live Q & A session on Friday, Oct. 29.

The live discussion will be held at noon on both the @MottChildren and @MichiganMedicine Facebook pages as well as the @MottChildren and @UMichMedicine Twitter accounts and the Michigan Medicine YouTube channel.

COVID-19 vaccine authorization for younger kids passed a critical step this week after Federal Drug Administration advisors voted in support of the Pfizer vaccine for ages 5-11.

If the vaccine is cleared through the next regulatory steps and is officially authorized, millions of more school-aged kids could qualify for COVID vaccination as early as the first week of November.

“We are getting closer to a major milestone of kids under 12 being eligible for COVID-19 vaccination,” said Luanne Thomas Ewald, FACHE, M.H.A., chief operating officer at Mott and Von Voigtlander Women’s Hospital and who will moderate the live virtual event.

“We know many families are eager to protect their younger children against COVID, but many may also want to learn more as they make this decision for their families. We will host a respectful discussion with our experts who will respond to parents’ top questions and concerns.”

Panelists will include pediatric infectious diseases expert Elizabeth Lloyd, M.D., pediatric cardiologist Jesse Hansen, M.D., and pediatric hospitalist Christine Mikesell, M.D.

Attendees may ask questions live at the time of the event. The video of the chat will also be available afterwards. More information.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Illustration of three older women playing cards at a table
Health Lab
Research needed on support for nontraditional caregivers providing care for people with Alzheimer’s disease and related dementias
A growing number of people living with Alzheimer’s disease and related dementias – especially those from diverse backgrounds – receive care from a network of individuals that increasingly includes nontraditional informal caregivers.
Aerial view of University of Michigan Health hospital in Ann Arbor, Michigan.
News Release
University of Michigan Health purchases land in Troy for new clinical facility
University of Michigan Health will purchase 7.28 acres of vacant land at the former Kmart headquarters location. U-M Health plans to build a multi-specialty facility on the property to expand specialty clinical services and increase patient access to the Oakland County region
George Mashour, M.D., Ph.D. standing in front of a bookcase, smiling. He is wearing a dark suit, white shirt, dark striped tie and dark framed glasses.
News Release
George Mashour, M.D., Ph.D. appointed senior associate dean for faculty and faculty development
George A. Mashour, M.D., Ph.D., has been appointed senior associate dean for faculty and faculty development of the University of Michigan Medical School by the U-M Board of Regents, effective May 1, 2024.
c.s_mott_childrens_hospital
News Release
$5.4M pediatric emergency services fast track clinic to serve lower acuity cases
University of Michigan Health C.S. Mott Children’s Hospital plans to build a $5.4 million emergency services fast track clinic to treat children, teens and young adults with lower acuity conditions.
Close up image of red blood cells moving through veins
Health Lab
Discovery reveals how this common stinky gas is processed to promote blood vessel growth
A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.
Closeup of knee with caregiver holding the joint and examining it.
Health Lab
Lipid mediator Maresin 1 helps improve muscle regeneration
How lipid mediators -- potent regulators of the immune response after an injury -- varied with the acute loss of a large volume of skeletal muscle, also known as volumetric muscle loss (VML) is the focus of new research from the University of Michigan.